Based on current clinical evidence, the rough ordering from largest to smallest weight-loss effect is: Tirzepatide highest average weight loss Semaglutide significant weight loss Tesamorelin moderate weight loss, primarily through visceral fat reduction AOD-9604 primarily body composition effects MOTS-c primarily metabolic and energy effects rather than pure weight reduction AOD-9604 and MOTS-c are generally not considered replacements for GLP-1 medications in patients seeking substantial weight reduction
Sometimes the major complaint is dissatisfaction with the act of defecation or the sense of incomplete evacuation after defecation
Even at the lowest starting dose, your body is adjusting to changes in appetite, digestion, and blood sugar regulation, all of which can temporarily affect your energy levels
This provides valuable information for creating a targeted treatment plan
Think of it as turning up the clarity and evenness of the skin you already have, gradually, especially when you pair it with proper sun protection and a solid routine